PH23645A - Pharmaceutically active pyrazolo 4,3-c) pyridines and method of use thereof - Google Patents
Pharmaceutically active pyrazolo 4,3-c) pyridines and method of use thereofInfo
- Publication number
- PH23645A PH23645A PH28489A PH28489A PH23645A PH 23645 A PH23645 A PH 23645A PH 28489 A PH28489 A PH 28489A PH 28489 A PH28489 A PH 28489A PH 23645 A PH23645 A PH 23645A
- Authority
- PH
- Philippines
- Prior art keywords
- pyridines
- pharmaceutically active
- pyrazolo
- active pyrazolo
- neuroleptic
- Prior art date
Links
- 150000003222 pyridines Chemical class 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003276 anti-hypertensive effect Effects 0.000 abstract 1
- 230000003177 cardiotonic effect Effects 0.000 abstract 1
- 239000003874 central nervous system depressant Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003176 neuroleptic agent Substances 0.000 abstract 1
- 230000000701 neuroleptic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8204722 | 1982-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH23645A true PH23645A (en) | 1989-09-27 |
Family
ID=10528419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH28489A PH23645A (en) | 1982-02-17 | 1983-02-08 | Pharmaceutically active pyrazolo 4,3-c) pyridines and method of use thereof |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4500525A (OSRAM) |
| EP (1) | EP0086422B1 (OSRAM) |
| JP (1) | JPS58152885A (OSRAM) |
| KR (1) | KR900006853B1 (OSRAM) |
| AT (1) | ATE30027T1 (OSRAM) |
| AU (1) | AU563591B2 (OSRAM) |
| CA (1) | CA1225646A (OSRAM) |
| DE (1) | DE3373904D1 (OSRAM) |
| DK (1) | DK27383A (OSRAM) |
| ES (3) | ES8500273A1 (OSRAM) |
| GR (1) | GR78080B (OSRAM) |
| IE (1) | IE55156B1 (OSRAM) |
| IL (1) | IL67785A0 (OSRAM) |
| NZ (1) | NZ203302A (OSRAM) |
| PH (1) | PH23645A (OSRAM) |
| ZA (1) | ZA83628B (OSRAM) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5137890A (en) * | 1990-02-14 | 1992-08-11 | Ortho Pharmaceutical Corporation | 4-phenyl tetrahydropyrido(4,3-d)pyrimidines |
| US5264576A (en) * | 1992-10-22 | 1993-11-23 | Hoechst-Roussel Pharmaceuticals Incorporated | Pyrazolo[4,3-c]pyridines which are intermediates |
| DE19834044A1 (de) * | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
| US20070105841A1 (en) * | 2000-08-14 | 2007-05-10 | Breitenbucher J G | Method for treating allergies using substituted pyrazoles |
| US20070117785A1 (en) * | 2000-08-14 | 2007-05-24 | Butler Christopher R | Substituted pyrazoles and methods of treatment with substituted pyrazoles |
| MXPA03001421A (es) * | 2000-08-14 | 2004-01-26 | Johnson & Johnson | Pirazoles sustituidos. |
| US20050101587A9 (en) * | 2000-08-14 | 2005-05-12 | Butler Christopher R. | Method for treating allergies using substituted pyrazoles |
| US7332494B2 (en) | 2000-08-14 | 2008-02-19 | Janssen Pharmaceutica, N.V. | Method for treating allergies using substituted pyrazoles |
| BRPI0113286B8 (pt) | 2000-08-14 | 2021-05-25 | Johnson & Johnson | pirazóis substituídos e composição farmacêutica compreendendo os mesmos. |
| ATE324372T1 (de) * | 2000-08-14 | 2006-05-15 | Ortho Mcneil Pharm Inc | Substituierte pyrazole |
| MXPA03001964A (es) * | 2000-09-06 | 2004-03-26 | Johnson & Johnson | Metodo para el tratamiento de alergias usando pirazoles substituidos. |
| CA2421502A1 (en) | 2000-09-06 | 2002-03-14 | Ortho-Mcneil Pharmaceutical, Inc. | A method for treating allergies |
| RU2286343C2 (ru) * | 2001-08-10 | 2006-10-27 | Орто-Макнейл Фармасьютикал, Инк. | Замещенные пиразолы |
| JP2005528443A (ja) | 2002-05-30 | 2005-09-22 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ｊａｋキナーゼおよびｃｄｋ２プロテインキナーゼのインヒビター |
| AU2003244632A1 (en) * | 2002-07-25 | 2004-02-25 | Pharmacia Italia S.P.A. | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| EP2243781A1 (en) * | 2003-05-30 | 2010-10-27 | Vertex Pharmaceuticals, Inc. | Pyrazolopyridine derivatives as inhibitors of JAK and CDK2 protein kinases |
| EA010905B1 (ru) * | 2003-09-17 | 2008-12-30 | Янссен Фармацевтика Н.В. | Сопряжённые гетероциклические соединения |
| JP2007506787A (ja) | 2003-09-23 | 2007-03-22 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼインヒビターとしてのピラゾロピロール誘導体 |
| KR100838692B1 (ko) | 2007-07-11 | 2008-06-16 | 한국화학연구원 | 7-(3′,4′-디알콕시페닐)-4,5,6,7-테트라히드로피라졸로[1,5-ａ]피리미딘 화합물, 이의 제조방법 및 이를 포함하는천식 및 만성폐쇄성 폐질환을 포함한 염증관련 질환,관절염, 아토피 피부염, 암 및 뇌질환의 치료 및 예방을위한 약제학적 조성물 |
| US9242981B2 (en) | 2010-09-16 | 2016-01-26 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel ERK inhibitors |
| AU2011376747B2 (en) * | 2011-09-12 | 2017-03-30 | Sanofi | Indanyl-substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them |
| WO2013037736A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | Indanyl-substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them |
| JP5957525B2 (ja) * | 2011-09-16 | 2016-07-27 | サノフイ | 置換された、４，５，６，７−テトラヒドロ−１Ｈ−ピラゾロ［４，３−ｃ］ピリジン、医薬としてのそれらの使用、及びそれらを含む医薬製剤 |
| WO2013037914A1 (en) | 2011-09-16 | 2013-03-21 | Sanofi | Substituted 4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising them |
| JP6713465B2 (ja) * | 2014-12-30 | 2020-06-24 | ノヴィラ・セラピューティクス・インコーポレイテッド | Ｂ型肝炎感染症治療のための誘導体及び方法 |
| JP7014736B2 (ja) * | 2016-05-24 | 2022-02-01 | ジェネンテック， インコーポレイテッド | がんの処置のためのピラゾロピリジン誘導体 |
| US10987359B2 (en) | 2016-06-29 | 2021-04-27 | Novira Therapeutics, Inc. | Oxadiazepinone derivatives and methods of treating hepatitis B infections |
| MA45550A (fr) | 2016-06-29 | 2019-05-08 | Novira Therapeutics Inc | Dérivés de diazépinone et leur utilisation dans le traitement des infections par l'hépatite b |
| KR102638253B1 (ko) | 2017-05-31 | 2024-02-16 | 케모센트릭스, 인크. | C5a 억제제로서의 6-5 융합 고리 |
| MX2020006459A (es) * | 2017-12-22 | 2020-11-06 | Chemocentryx Inc | Compuestos de anillos fusionados 6,5 diaril sustituidos como inhibidores de c5ar. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3852279A (en) * | 1973-03-12 | 1974-12-03 | Squibb & Sons Inc | 7-substituted -3,3a,4,5,6,7-hexahydro-3-substituted-2h- pyrazolo (4,3-c)pyridines |
-
1983
- 1983-01-25 DK DK27383A patent/DK27383A/da not_active Application Discontinuation
- 1983-01-31 IL IL67785A patent/IL67785A0/xx unknown
- 1983-01-31 ZA ZA83628A patent/ZA83628B/xx unknown
- 1983-02-03 GR GR70399A patent/GR78080B/el unknown
- 1983-02-06 DE DE8383101109T patent/DE3373904D1/de not_active Expired
- 1983-02-06 AT AT83101109T patent/ATE30027T1/de not_active IP Right Cessation
- 1983-02-06 EP EP83101109A patent/EP0086422B1/en not_active Expired
- 1983-02-08 PH PH28489A patent/PH23645A/en unknown
- 1983-02-10 AU AU11305/83A patent/AU563591B2/en not_active Expired - Fee Related
- 1983-02-15 KR KR1019830000609A patent/KR900006853B1/ko not_active Expired
- 1983-02-15 US US06/466,701 patent/US4500525A/en not_active Expired - Fee Related
- 1983-02-16 ES ES519832A patent/ES8500273A1/es not_active Expired
- 1983-02-16 IE IE328/83A patent/IE55156B1/en not_active IP Right Cessation
- 1983-02-16 CA CA000421751A patent/CA1225646A/en not_active Expired
- 1983-02-16 NZ NZ203302A patent/NZ203302A/en unknown
- 1983-02-17 JP JP58023893A patent/JPS58152885A/ja active Granted
-
1984
- 1984-04-27 ES ES531980A patent/ES531980A0/es active Granted
- 1984-04-27 ES ES531981A patent/ES531981A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ES519832A0 (es) | 1984-10-01 |
| IL67785A0 (en) | 1983-05-15 |
| IE830328L (en) | 1983-08-17 |
| JPH0412269B2 (OSRAM) | 1992-03-04 |
| GR78080B (OSRAM) | 1984-09-26 |
| EP0086422B1 (en) | 1987-09-30 |
| ZA83628B (en) | 1983-12-28 |
| ES8507547A1 (es) | 1985-09-01 |
| JPS58152885A (ja) | 1983-09-10 |
| EP0086422A3 (en) | 1984-03-28 |
| DE3373904D1 (en) | 1987-11-05 |
| CA1225646A (en) | 1987-08-18 |
| NZ203302A (en) | 1986-08-08 |
| IE55156B1 (en) | 1990-06-20 |
| ES8507546A1 (es) | 1985-09-01 |
| KR840003636A (ko) | 1984-09-15 |
| DK27383A (da) | 1983-08-18 |
| AU563591B2 (en) | 1987-07-16 |
| AU1130583A (en) | 1983-08-25 |
| ATE30027T1 (de) | 1987-10-15 |
| US4500525A (en) | 1985-02-19 |
| ES8500273A1 (es) | 1984-10-01 |
| ES531980A0 (es) | 1985-09-01 |
| EP0086422A2 (en) | 1983-08-24 |
| KR900006853B1 (ko) | 1990-09-22 |
| DK27383D0 (da) | 1983-01-25 |
| ES531981A0 (es) | 1985-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH23645A (en) | Pharmaceutically active pyrazolo 4,3-c) pyridines and method of use thereof | |
| HUT70505A (en) | Pyrrolo[2,3-d]pyrimidine derivatives, pharmaceutical compositions containing them and process for preparing them | |
| IL72120A (en) | 2-pyrimidinyl-1-piperazine derivatives,their preparation and pharmaceutical compositions containing them | |
| YU211087A (en) | Process for obtaining new n-substituted benzimidazolic derivatives | |
| DE3571982D1 (en) | Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds | |
| HUT38897A (en) | Process for producing pharmaceutically active substituted benzamides and pharmaceutical compositions containing them as active agents | |
| PT77370B (en) | Process for preparing new pyrazolo <3,4-b> piridine derivatives and pharmaceutical preparations containing the same | |
| MX9403088A (es) | Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso. | |
| JO1406B1 (en) | Chemical compounds | |
| ZA848140B (en) | New benzenesulfonyl-lactams,process for their preparation and their use as active substances of pharmaceutical compositions | |
| ES8305684A1 (es) | Procedimiento para la obtencion de derivados aminopropanolicos de 2-hidroxi b-fenil-propiofenonas. | |
| ZA848141B (en) | New cyclic benzensulfonamides,process for their preparation and their use as active substance of pharmaceutical compositions | |
| AU573899B2 (en) | Pyrazolo(3,4-b)-pyridine amided | |
| ES8800217A1 (es) | Procedimiento para la preparacion de acidos 4-(isoxazolil)-tiazol-2-oxamicos y sus derivados | |
| ES8802612A1 (es) | Procedimiento para preparar derivados de benzisoselenazolilo | |
| ES8407021A1 (es) | Un procedimiento para la preparacion de derivados de acido 5-oxo-2-pirrolidinpropanoico. | |
| IL68194A0 (en) | Pharmaceutical preparation containing indolizino indole derivatives,novel compounds of this type and process for their preparation | |
| ES8502421A1 (es) | Procedimiento para preparar 2-alquiltio-1-aminoalquil-2-pirrolin-3-carbonitrilos |